According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:
- there had been certain improprieties in Exicure’s preclinical program for the treatment of Friedreich’s ataxia;
- as a result, there was a material risk that data from the preclinical program would not support continued clinical development; and
- as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Attorney Advertising. Prior results do not guarantee a similar outcome.